← Open Payments lookup

COLLEEN ADKINS: Open Payments

NPI 1346690856 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$375 in 15 payments from 10 companies in 2025. Trend: 2023 $502 · 2024 $539 · 2025 $375

Food & beverage: $375
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$79
Janssen Biotech, Inc.2$56
ABBVIE INC.2$55
PFIZER INC.2$40
Celgene Corporation1$28
Novartis Pharmaceuticals Corporation1$27
ARRAY BIOPHARMA INC1$27
GENZYME CORPORATION1$22
Incyte Corporation1$22
SOBI, INC1$19

Products named: RYBREVANT, IMBRUVICA, IMFINZI, OPDIVO, SCEMBLIX, BRAFTOVI, ENHERTU, EPKINLY.

Industry payments across TX — which companies pay providers there.